Cidara Therapeutics (CDTX) PT Raised to $47 at Citizens JMP
Tweet Send to a Friend
Citizens JMP analyst Roy Buchanan raised the price target on Cidara Therapeutics (NASDAQ: CDTX) to $47.00 (from $46.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
